Find your next paid study

University of FloridaNCT07406490

~$10 – $750

Human Papillomavirus VaccinationEmotions

Stories to Prevent (StoP) HPV Cancers: A Communication Intervention to Increase HPV Vaccination Among Diverse Populations.

This randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates amon…

Milton S. Hershey Medical CenterNCT06808776

Phase 1

A Phase 1 Study of SynKIR-310, Autologous T Cells Transduced With CD19 KIR-CAR, in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

This first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administ…

B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more

Human Immunodeficiency VirusChronic Neuropathic Pain

~$10 – $8,750

Phase 4

Low Dose Naltrexone (LDN) for the Treatment of Chronic Neuropathic Pain in Patients With Human Immunodeficiency Virus (HIV), a Prospective, Pragmatic, Open Label Clinical Trial

The increased life expectancy of Patients Living With HIV/AIDS (PLWHA) has increased the need for therapies for chronic conditions, such as chronic pain. Pain …

Emory UniversityNCT05537935

Phase 4

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical c…

Human Immunodeficiency Virus (HIV)Smoking Cessation

New York UniversityNCT06598397

Opioid Use DisorderHIVHepatitis C Virus+6 more

Integrating Infectious Diseases Screening and Treatment With Medication Assisted Therapy for Veterans With Opioid Use Disorder

Opioid use disorder (OUD) confers a higher risk of acquiring and transmitting infectious diseases, which may have long-term health consequences in Veterans. Tr…

VA Office of Research and DevelopmentNCT06766331

~$10 – $5,625

ReMARk: A Multi-level Intervention Addressing Disparities in Rural HPV-related Cancer Prevention: Part 3- Evaluation

There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (remi…

Papillomavirus Vaccines

University of FloridaNCT06535139

HIV PreventionSexually Transmitted Infections (STI)Preexposure Prophylaxis (PrEP)+3 more

California Hub for HIV/STI/SUD Prevention Research With Reentry Populations

The California Hub for HIV/SUD Prevention Research with Reentry Populations addresses the question: "Can the evidence-based MEPS intervention be adapted and im…

University of California, Los AngelesNCT07433985

Phase 2

A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections With Related Donor CMV Specific Cytotoxic T-cells (CTLs) in Children, Adolescents and Young Adult Recipients

CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young a…

Cytomegalovirus InfectionsPrimary Immune Deficiency Disorder

New York Medical CollegeNCT03266640

Phase 1

Antigen Specific Adoptive T Cell Therapy for Opportunistic Cytomegalovirus Infection Occurring After Stem Cell Transplant

The purpose of this study is to determine if a specific type of cell-based immunotherapy, using T-cells from a donor that are specific against cytomegalovirus …

Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantOpportunistic Infections

CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more

~$10 – $7,500

Mari DallasNCT02982902

Phase 4

Exploratory Use of CMV Immunoglobulin in High Risk (D+R-) Transplant Recipients at the End of Antiviral Prophylaxis to Decrease the Risk of Late CMV Infection

This study is being done to find out if administering CytoGam® after the end of standardly prescribed preventive antiviral treatment can help transplant recipi…

Camille N. Kotton, MDNCT06958796

~$10 – $7,500

A Prospective, Non-interventional, Observational Clinical Validation Study to Analytically Validate the A&M Breathalyzer PROTECT Kiosk Breath Capture System.

The primary objective of this effort will be to optimize and operationalize innovative passive surveillance systems and in parallel, the effort will identify, …

COVID-19SARS CoV 2 VirusCOVID-19 Pneumonia+2 more